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Background: Pathogenic bacteria are able to develop various strategies to counteract the bacte-
ricidal action of antibiotics. Silver nanoparticles (AgNPs) have emerged as a potential alternative 
to conventional antibiotics because of their potent antimicrobial properties. The purpose of this 
study was to synthesize chitosan-stabilized AgNPs (CS-AgNPs) and test for their cytotoxic, 
genotoxic, macrophage cell uptake, antibacterial, and antibiofilm activities.
Methods: AgNPs were synthesized using chitosan as both a stabilizing and a reducing agent. 
Antibacterial activity was determined by colony-forming unit assay and scanning electron 
microscopy. Genotoxic and cytotoxic activity were determined by DNA fragmentation, comet, 
and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assays.   Cellular 
uptake and intracellular antibacterial activity were tested on macrophages.
Results: CS-AgNPs exhibited potent antibacterial activity against different human pathogens 
and also impeded bacterial biofilm formation. Scanning electron microscopy analysis indicated 
that CS-AgNPs kill bacteria by disrupting the cell membrane. CS-AgNPs showed no significant 
cytotoxic or DNA damage effect on macrophages at the bactericidal dose. Propidium iodide 
staining indicated active endocytosis of CS-AgNPs resulting in reduced intracellular bacterial 
survival in macrophages.
Conclusion: The present study concludes that at a specific dose, chitosan-based AgNPs kill 
bacteria without harming the host cells, thus representing a potential template for the design 
of antibacterial agents to decrease bacterial colonization and to overcome the problem of drug 
resistance.
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Introduction
Bacterial infections are still a leading cause of death for millions of people worldwide. 
This is primarily because of the emergence of new disease agents and the   development 
of multidrug-resistant strains. Moreover, the pathogens have evolved effective 
approaches to counteract the biocidal action of antibacterial molecules. As a result, even 
though many antibiotics have been developed, very few antibiotics have proved effec-
tive against multidrug-resistant bacteria. Therefore, it is extremely important to design 
and develop new antibiotics that overcome these limitations. Recently, nanoparticles 
have been used successfully for the delivery of therapeutic agents,1 in chronic disease 
diagnostics,2 to reduce bacterial infections,3 and in the food and clothing industries 
as an antimicrobial agent.4 Because of their potent antimicrobial activity and unique 
mode of action, nanoparticles offer an attractive alternative to conventional antibiotics 
in the development of new-generation antibiotics. Of the range of nanoparticle options 
available, silver nanoparticles (AgNPs) have received intensive interest because of their 
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various applications in the medical field.5 Although silver has 
been used as an antimicrobial substance for centuries,6 it is 
only recently that researchers have shown unprecedented 
interest in this element as a therapeutic agent to overcome the 
problem of drug resistance caused by the abuse of antibiot-
ics.7,8 The mechanism by which silver exerts its bioactivity 
is still only poorly understood. It has been reported that the 
mode of antibacterial action of silver ions is probably similar 
to that of AgNPs.9 It is generally recognized that AgNPs may 
attach to the microbial cell wall and thus exert a toxic effect 
by disturbing cell wall permeability. The nanoparticles may 
also penetrate the cell and affect cellular respiration through 
inactivating the essential enzymes by forming complexes with 
the catalytic sulfur of thiol groups in cysteine residues10 and 
through the production of toxic radicals such as superoxide, 
hydrogen peroxide, and hydroxyl ions. In addition to their 
direct bactericidal activity, nanoparticles are also known to 
disrupt biofilm formation.11 Biofilms are formed because of 
the attachment of bacteria to the solid surfaces resulting in the 
agglomeration of bacterial cells. Biofilms augment resistance 
to drug therapy and disinfectants and they help pathogens 
evade host immune responses and establish chronic infec-
tions. AgNPs also exhibit genotoxic and cytotoxic effects in 
human tissue culture, causing DNA damage, chromosome 
aberrations, and cell death if they are directly applied above 
a certain concentration level.12
To date, numerous methods concerning the fabrication 
of AgNPs have been developed.13–16 Among the synthetic 
  methods, a chemical reduction of silver salt solution using 
reducing agents such as sodium dodecyl sulfate, citrate, 
  ascorbate, hyperbranched polyester, N,N-dimethylformamide, 
and sodium borohydride is most commonly used.16–18 Most 
of these reducing agents lead to environmental toxicity 
or biological hazards; therefore, the trend has shifted to 
  biological synthesis of AgNPs using polymer matrices, as 
they have no toxicity risks and they can be easily designed 
into almost any shape required for a particular application. 
This includes the use of different biopolymers such as 
starch,19 chitosan,6 cyclodextrins,20 and bacterial biomass21 
that act as both a stabilizing and a reducing agent. Recently, 
the authors reported the synthesis of green AgNPs using the 
cell biomass of Cochliobolus lunatus.22 Similarly, other stud-
ies have shown that exposure of silver ions to Trichoderma 
viride21 and Escherichia coli23 filtrate resulted in the reduction 
of silver ions and the formation of extremely stable silver 
particles. The use of biopolymers in nanoparticle preparation 
has several advantages over conventional synthetic chemical 
agents. Macromolecular chains of these biopolymers possess 
a large number of hydroxyl groups and so they can complex 
well with metal ions – this further enables control of size, 
shape, and dispersion of nanoparticles – and they are less 
toxic to mammalian cells.
In the present study, chitosan was used for the synthesis 
of stable AgNPs. Chitosan, a positively charged polysac-
charide biopolymer derived from chitin, exhibits a number 
of interesting biological properties such as antimicrobial 
activity, chelating and polycationic properties, biodegrad-
ability, biocompatibility, the ability to induce disease resis-
tance in plants, and display of stimulating or inhibiting 
activities toward human cells.24,25 For these reasons, chitosan 
has received great attention in the fields of medicine, food, 
chemicals, pharmaceuticals, and agriculture.26–29
Although several independent studies have shown 
  applications of nanoparticles in various fields, studies 
  describing their impact on counteracting bacterial   infections 
are limited. In this study, chitosan-stabilized AgNPs 
  (CS-AgNPs) were synthesized, characterized by transmission 
electron microscopy (TEM) and dynamic light scattering, 
and tested for antibacterial activity against a panel of human 
pathogens such as Staphylococcus aureus, Pseudomonas 
aeruginosa, Salmonella typhi, and Mycobacterium   smegmatis, 
representing Gram-positive, Gram-negative, and acid-fast 
bacteria. These bacteria are known to infect humans through 
exposure to contaminated air, food, and water, and they are 
responsible for serious communicable and noncommuni-
cable diseases. Moreover, these pathogens are posing serious 
problems because of the emergence of multidrug-resistant 
strains. In this article the authors report that CS-AgNPs 
exhibit potent antibacterial activity against the   aforementioned 
human   pathogens and impede biofilm formation. Single 
cell gel   electrophoresis (comet), nucleus staining, and DNA 
  fragmentation assays indicated that CS-AgNPs do not cause 
DNA   damage of host cells after treatment with a bactericidal 
dose of nanoparticles. Moreover, macrophages actively 
  endocytose propidium iodide (PI)-labeled CS-AgNPs, 
  resulting in the intracellular killing of M. smegmatis. The 
combined data support the   biomedical application of CS-
AgNPs as an antibacterial therapeutic agent.
Materials and methods
Bacterial strains and reagents
P . aeruginosa PAO1, S. typhi, and S. aureus were grown 
in Luria Bertani (LB) medium at 37°C on a shaker (180 rpm). 
Chitosan, low melting point agarose, DAPI (4, 6-diami-
dino-2-phenylindole), and crystal violet were purchased 
from Sigma-Aldrich (St Louis, MO). MTT [3-(4,5-  dimethylt
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hiazol-2-yl)-2,5-diphenyltetrazolium   bromide] was purchased 
from MP Biomedicals United States (Solon, OH). Silver 
nitrate (AgNO3) was obtained from Fisher Scientific (Mumbai, 
India). PI was purchased from Invitrogen (Carlsbad, CA). 
The mouse macrophage cell line RAW264.7 was cultured in 
Dulbecco’s modified Eagle’s medium (DMEM; HIMEDIA, 
Mumbai, India)   supplemented with 10% fetal calf serum, 1% 
penicillin-streptomycin  solution, 1% L-glutamine and HEPES 
[4-(2-hydroxyethyl)-1-  piperazineethanesulfonic acid].
Synthesis of chitosan-based AgNPs
High-molecular-weight chitosan (.75% deacetylated) was 
used for the synthesis of AgNPs. Chitosan solution (1 mg/mL) 
was prepared in 1% acetic acid and the mixture was stirred at 
45°C to obtain a homogeneous solution. The chitosan solu-
tion (24 mL) was then mixed with 0.1 N sodium hydroxide 
(NaOH) solution (75 mL) and 100 mM AgNO3 solution 
(1 mL) was added to the resulting suspension. Change to a 
yellow appearance indicated the formation of AgNPs. After 
being allowed to settle, the suspension was washed twice with 
sterile distilled water (dH2O) and centrifuged at 2000 rpm 
for 5 minutes. The final pellet was dried and dissolved in 
0.1% acetic acid, resulting in a yield of 136 ppm. A range 
of CS-AgNP concentrations were used to treat the bacteria 
and for other experiments in this study.
Quantitative determination 
of chitosan in CS-AgNPs
The ninhydrin method was used for quantitative analysis 
of chitosan present in CS-AgNPs.30 Ninhydrin reagent was 
prepared by dissolving ninhydrin (0.5 g) in isopropanol 
(30 mL). The resulting solution was mixed with 20 mL of 
sodium acetate buffer (pH 5.5). A chitosan standard curve 
ranging from 10 µg/mL to 1 mg/mL was determined, and 
this was used to calculate the quantity of chitosan present 
in freshly prepared (day 1) and old (day 30) CS-AgNPs. 
Ninhydrin reagent (1 mL) was added to test samples (1 mL) 
and boiled for 30 minutes. The solution was then cooled to 
30°C and diluted with 50% ethanol (5 mL). The absorbance 
at 570 nm was measured on an ultraviolet (UV) and visible 
spectrophotometer (UV-1800; Shimadzu, Kyoto, Japan).
Nanoparticle characterization
UV and visible spectroscopy were used to characterize 
  synthesized nanoparticles, with an Epoch UV-Vis spectro-
photometer (BioTek Germany, Bad Friedrichshall, Germany) 
at a resolution of 1 nm from 200 to 900 nm. For TEM analysis, 
a drop of aqueous solution containing the CS-AgNPs was 
placed on carbon-coated copper grids. The samples were 
dried and kept under a desiccator before then being loaded 
onto a specimen holder. The TEM measurements were 
performed on a Tecnai® G2 transmission   electron micro-
scope (FEI Company, Hillsboro, OR) operating at 200 kV . 
The size distribution and zeta potential of the chitosan and 
CS-AgNPs were determined by dynamic light scattering 
(Zetasizer Nano ZS; Malvern Instruments Ltd, Malvern, 
Worcestershire, UK).
In vitro killing assay
To determine the antibacterial activity of the CS-AgNPs, 
cultures grown overnight were centrifuged at 5000 rpm for 
5 minutes, washed with 1 × phosphate-buffered saline (PBS), 
and the final pellet suspended in LB medium. Finally, the 
optical density of the sample was adjusted to 0.1 at 600 nm. 
Various concentrations of the CS-AgNPs were incubated 
with 4 or 5 × 105 bacteria in LB medium in 96-well round-
bottom plates, and this was performed in triplicate. Bacteria 
were harvested at the indicated time points and the number 
of colony-forming units (CFUs) was assayed. All samples 
were plated in triplicate and values were averaged from three 
independent trials.
Diffusion assay
Bacterial cultures were grown overnight in LB medium and 
centrifuged at 5000 rpm for 5 minutes. The final pellet was 
washed with 1 × PBS and resuspended in LB medium. The 
suspended culture (100 µL) was spread uniformly on LB 
plates and the plates were incubated at 37°C for 30 minutes. 
Different concentrations of CS-AgNPs were loaded into the 
wells. The zone of inhibition was determined by measuring 
the diameter of the zone of inhibition after 24 hours.
Cytotoxic assay
To determine the cytotoxic activity of the CS-AgNPs on mac-
rophages, RAW264.7 cells (1 × 104 cells/mL) were grown 
in DMEM in a 96-well plate at 37°C in an atmosphere of   
5% carbon dioxide (CO2) for 24 hours, followed by   treatment 
of the cells with different concentrations of CS-AgNPs for 
another 24 hours. To determine the cell viability, MTT   
(at a concentration of 0.1 mg/mL) was added to the wells and 
incubated for 4 hours at 37°C in an atmosphere of 5% CO2 
in the dark. In metabolically active cells, MTT was reduced 
to an insoluble, dark purple formazan. The formazan crystals 
were dissolved in dissolving buffer (sodium dodecyl sulfate 
[SDS] [11 g] in 0.02 M hydrochloric acid [HCl] [50 mL] 
and isopropanol [50 mL]). The absorbance was read at 
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570 nm using an enzyme-linked immunosorbent assay reader 
(BioTek Germany) and compared with the untreated cells, 
and the percentage of viable cells was calculated.
DNA fragmentation assay
The effect of CS-AgNPs on macrophage DNA fragmentation 
was determined as described previously.31 Briefly, RAW264.7 
cells (1 × 106 cells/mL) were seeded in a six-well plate and 
treated with different concentrations of CS-AgNPs. The cells 
were trypsinized at 6 hours and pelleted, and genomic DNA was 
isolated by the phenol-chloroform extraction method. The cell 
pellet was washed with PBS, lysed by the addition of lysis buffer 
(10 mM ethylenediaminetetraacetic acid [EDTA], 0.5% Triton® 
X-100, 5 mM Tris [2-amino-2-hydroxymethyl-propane-1,3-diol] 
HCl, pH 8.0) and incubated on ice for 30 minutes. Samples were 
centrifuged and the supernatant was treated with ribonuclease A 
for 1 hour, followed by digestion with   proteinase K (0.5 mg/mL) 
(Roche, Mannheim, Germany) for 3 hours at 50°C. Phenol-
chloroform-isoamyl alcohol (25:24:1) extraction was performed 
and the DNA was precipitated with 2.5 volumes of 95% ethanol 
and one-tenth volume of 3 M sodium acetate (pH 5.2). DNA 
was dissolved and electrophoresed in 1.5% agarose gel at 40 V . 
The gel was stained with ethidium bromide and DNA fragments 
were visualized under UV light.
Cellular uptake studies
CS-AgNPs were labeled with PI, as described previously.32 CS-
AgNPs dispersed in DMEM were mixed with PI (0.1 µg/mL) 
and the mixture was incubated at room temperature for 2 hours. 
RAW264.7 cells (1 × 105 cells/mL) were grown on glass cov-
erslips. PI-labeled nanoparticles were added to the cells and 
incubated for 1 hour. The cells were washed several times with 
1 × PBS and fixed with 3.7% paraformaldehyde for 30 minutes 
at 37°C. After incubation, cells were washed with 1 × PBS and 
mounted on glass slides. The images were visualized using a 
fluorescence microscope (ECLIPSE-Ti; Nikon, Tokyo, Japan).
Comet assay
The alkaline comet assay was performed to check the effect 
of CS-AgNP treatment on DNA damage. Macrophages were 
treated with CS-AgNPs (3 and 20 ppm) for 6 hours at 37°C 
in an atmosphere of 5% CO2. Untreated cells were used as a 
control. Cells were trypsinized and cell suspension (400 µL) 
was mixed with 1% low melting point agarose (1 mL). 
The mixture was added to glass cavity slides (Blue Label   
Scientifics Pvt Ltd, Mumbai, India). The agarose was allowed 
to solidify and then the slides were submerged in lysis solution 
(1.2 M sodium chloride, 100 mM EDTA disodium salt, 0.1% 
SDS, 0.26 M NaOH [pH . 13]) for 2 hours at 4°C in the dark. 
After lysis, the slides were washed with dH2O, transferred to 
an   electrophoresis unit, covered with freshly prepared electro-
phoresis buffer (0.03 M NaOH, 2 mM EDTA disodium salt 
[pH 12.3]), left for unwinding of DNA for 30 minutes, and the 
cells were electrophoresed for 20 minutes at 22 V and 200 mA. 
The cells were neutralized with neutralization buffer (500 mM 
Tris HCl, pH 8.0) for 15 minutes, washed 3–4 times with dH2O, 
and stained with PI (4 µg/mL) for 1 hour. The slides were dried 
and then observed using the fluorescence microscope.
Effect on intracellular killing 
of M. smegmatis
To examine whether treatment with CS-AgNPs increases the 
killing efficiency of macrophages, 5 × 105 RAW264.7 cells 
were  treated  with AgNPs  (3  ppm)  1  hour  before 
Mycobacterium smegmatis   infection – referred to as “pre-
treated,” whereas in   “post-treated”   conditions macrophages 
were treated with the same   concentration of CS-AgNPs but 
1 hour post infection.   Pretreated cells were washed with PBS, 
and fresh media without the AgNPs was added to the wells prior 
to infection. Untreated, pretreated, and post-treated cells were 
exposed to M. smegmatis at a   multiplicity of infection of 10 for 
1 hour, and extracellular bacteria were killed by the addition of 
gentamicin (20 µg/mL). Macrophages treated with chitosan 
alone were used as a control. After the incubation period, cells 
were washed and lysed with 0.5% Triton X-100; intracellular 
survival was estimated by plating serially diluted cultures on 
7H10 plates and the colonies were enumerated after 72 hours.
Biofilm assay
Cultures grown overnight were diluted 1:100 in fresh LB 
medium. Diluted culture (2 µL) was added to the 96-well micro-
titer plate and incubated at 37°C for 24 hours without shaking. 
The wells were then washed with 1 × PBS to remove unbound 
cells. Different concentrations of CS-AgNPs were added to 
the wells and incubated at 37°C for 24 hours.   Thereafter, the 
medium was removed and the wells were thoroughly washed 
with 1 × PBS, and 0.1% (w/v) crystal violet (100 µL) was 
added and incubated for 20 minutes. The crystal violet was 
removed and washed thoroughly with 1 × PBS. For quantifica-
tion of attached cells the crystal violet was solubilized in absolute 
ethanol and the absorbance was measured at 575 nm. Reduction 
of the biofilm was compared with the untreated cells.
Statistical analysis
Statistically significant differences among groups were deter-
mined using the Student’s t-test (two-tailed, equal variances).
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Results
Characterization of  
chitosan-coated AgNPs
AgNO3 was reduced and stabilized with chitosan, and the UV 
and visible spectroscopy absorption spectrum of the resulting 
solution was measured. It is clear that the spectra displayed the 
characteristics of absorption at about 420 nm – a typical band 
for AgNPs (Figure 1A). The stability of the prepared solution 
was also determined by measuring its absorption spectrum at 
24-hour intervals over 30 days. No significant changes in the 
absorbance were observed during the storage, indicating that 
the AgNPs did not agglomerate and they were stable during this 
period (Figure 1A). The amount of chitosan leached from the 
freshly prepared (day 1) and old (day 30) CS-AgNPs was 
determined by the ninhydrin method. The amount of   chitosan 
present in the medium at days 1 and 30 was measured as 
987.27 and 813.63 µg/mL, respectively (data not shown). The 
shape of the CS-AgNPs was determined by TEM. A typical 
TEM micrograph showed spherical CS-AgNPs (Figure 1B). 
Dynamic light scattering showed predominantly two sizes of 
CS-AgNPs: 55 and 278 nm (Figure 1C). Surface zeta potential 
of chitosan and CS-AgNPs was measured as 36.3 and 51.1 mV , 
respectively (Figure 1D).
Antibacterial activity 
of chitosan-AgNP composites
The antibacterial activity of the CS-AgNPs against S. aureus, 
P . aeruginosa, S. typhi, and M. smegmatis was tested in 
96-well round-bottom plates by CFU assay. Exponentially 
grown bacteria were incubated with d  ifferent   concentrations 
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Figure 1 (A) Ultraviolet and visible spectroscopy absorption spectrum of the chitosan-stabilized silver nanoparticles (CS-AgNPs) (maximum absorbance at 420 nm); 
(B) transmission electron microscopy image of CS-AgNPs (scale bar, 100 nm); (C) size distribution and (D) zeta potential of chitosan and CS-AgNPs determined by dynamic 
light scattering.
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of CS-AgNPs, and the number of CFUs was analyzed 
through harvesting bacteria at different time points by plat-
ing serial dilutions on LB plates. The surviving colonies 
were enumerated after 24 hours for all bacteria except 
M. smegmatis, in which the colonies were enumerated   
after 72 hours. The results were compared with bacteria 
grown in LB medium (control) and the reaction mixture 
containing all the components except AgNO3 (chitosan). 
The control and the corresponding concentration of chitosan 
  statistically showed no antibacterial activity over the span of 
the study (Figure 2), suggesting no toxicity. In comparison, 
CS-AgNPs showed significant inhibitory activity toward 
P . aeruginosa, S. typhi, and S. aureus in a dose-dependent 
manner. As shown in Figure 2 (A–C), CS-AgNPs signifi-
cantly inhibited the growth of the aforementioned strains. 
After 1 hour of exposure to CS-AgNPs at 1 and 2 ppm, 
more than 60% and 75%, respectively, of the bacteria were 
killed, whereas after 4 hours of incubation more than 95% 
killing was observed, relative to the control and chitosan. In 
comparison, M. smegmatis was found to be less susceptible 
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Figure 2 Dose-dependent killing of bacterial strains by chitosan-stabilized silver nanoparticles (CS-AgNPs): (A) Pseudomonas aeruginosa, (B) Salmonella typhi, (C) Staphylococcus 
aureus, and (D) Mycobacterium smegmatis were incubated with different concentrations of CS-AgNPs. Bacterial survival was determined at 1 and 4 hours by colony-forming 
unit (CFU) assay. Media containing bacteria alone (control) and chitosan plus bacteria (chitosan) were used as controls. (E) Antibacterial activity of CS-AgNPs by diffusion 
method: CS-AgNPs at 100 ppm (20 µL) were loaded into wells formed on plates containing a lawn of P. aeruginosa; growth inhibition was determined by measuring the zone 
of inhibition after 24 hours; chitosan was used as a control. 
Notes: Experiments were performed in triplicate; results are shown as mean plus or minus standard deviation; *P # 0.05. 
Abbreviation: ND, bacterial growth not detected.
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to the inhibitory effect of CS-AgNPs, such that 5% and 37% 
of the bacteria were killed at 2 and 3 ppm after 3 hours’ 
incubation, but no killing was observed at 1 ppm. However, 
the loss of M. smegmatis viability steadily increased with 
extending incubation time, such that more than 50% and 
85% bacteria were killed at 2 and 3 ppm, respectively, after 
6 hours’ incubation (Figure 2D).
The bactericidal activity observed under in vitro conditions 
was also demonstrated by the zone inhibition method – a qualita-
tive method for measuring the antibacterial action. Following 
this method, CS-AgNPs were applied into a well formed 
on the Luria-Bertani (LB) agar plate (HIMEDIA) containing 
approximately 106 CFU/mL of the bacteria. After 24 hours of 
incubation, a plate loaded with CS-AgNPs (20 µL) showed a 
clear zone of inhibition of approximately 14 mm in diameter, 
while the plate loaded with all reaction components except 
AgNO3 (chitosan) showed a dense population of bacteria. 
Figure 2E shows a representative plate displaying the zone of 
inhibition of P . aeruginosa. Similar results were obtained with 
S. aureus (Figure S1).
Destruction of bacterial membrane
To find out how chitosan-based AgNPs kill bacteria, scan-
ning electron microscopy was used to illustrate interactions 
between CS-AgNPs and P . aeruginosa cells. Figure 3 shows 
how the P . aeruginosa cells lost their cellular integrity after 
exposure to CS-AgNPs at a concentration of 2 ppm, whereas 
untreated and chitosan-treated cells remained intact. Also, 
the authors observed that CS-AgNP treatment resulted in the 
formation of large aggregates.
Effect on biofilm formation
Biofilms limit the diffusion of drug molecules and   contribute 
to the pathogenesis of infection; therefore, the inhibition of 
biofilm formation is important to prevent   bacterial colonization 
and to increase the susceptibility to the administered drug. 
Among the bacteria tested in this study, P . aeruginosa and S. 
aureus are known for their ability to form biofilms by adhering 
to a surface and coating it with slime. The authors determined 
if treatment with CS-AgNPs inhibited this biofilm formation 
and/or disrupted the preformed biofilms under in vitro condi-
tions by monitoring the binding of the dye crystal violet to 
adherent cells that directly reflected effective ability in biofilm 
formation. To determine the effect on disruption of preformed 
biofilms, P . aeruginosa and S. aureus were allowed to form 
biofilms for 24 hours in a 96-well microtiter plate and were 
then treated with varying concentrations of CS-AgNPs; to 
study the inhibitory effect, CS-AgNPs were added to the bacte-
rial cultures before the biofilms were formed. No significant 
effect on the disruption of preformed biofilms was observed 
(data not shown). In contrast, early exposure of P . aeruginosa 
to CS-AgNPs significantly inhibited the formation of biofilm. 
Treatment for 24 hours with CS-AgNPs at 2 ppm decreased 
more than 65% of the biofilms formed; however, the effect 
was limited, as no further increase in biofilm inhibition was 
observed with increase in nanoparticle concentration (Fig-
ure 4A). In comparison, treatment of S. aureus with the same 
concentration (2 ppm) showed no significant reduction (22% 
inhibition); however, treatment with a higher dose (5 ppm) 
resulted in 65% inhibition of biofilm formation (Figure 4B).
Cytotoxic effect
Despite their potent antibacterial activity and wide range of 
biomedical applications, the use of AgNPs as   therapeutic 
agents is limited because of their cytotoxicity against 
  mammalian cells. It is known that the biopolymer coating 
of AgNPs can exert the antimicrobial activity of AgNPs, 
but it has no cytotoxic effect on mammalian cells, because 
of the slow release of silver ions from the gel matrix. As the 
majority of pathogens used in this study infect macrophages, 
Control 2 ppm CS-AgNPs
Figure 3 Scanning electron microscopy images of Pseudomonas aeruginosa after incubation with medium (control) and chitosan-stabilized silver nanoparticles (CS-AgNPs) 
(2 ppm) for 4 hours. 
Note: Scanning electron microscopy analysis was performed on a SU1510 scanning electron microscope (hitachi, Tokyo, Japan).
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the authors used the MTT assay to test the cytotoxicity in 
  macrophages treated with CS-AgNPs. MTT assay relies on 
the fact that metabolically active cells reduce MTT to purple 
formazan; hence, the intensity of dye read at 570 nm is directly 
proportional to the number of viable cells. The   cytotoxicity 
assay showed a concentration-dependent drop in cell viability 
(Figure 5). The cell viability was not   significantly affected 
at 24 hours of incubation in the   presence of 3 ppm, a dose 
that was found to be lethal for the bacteria tested in this 
study. Cell viability dropped drastically at the nanoparticle 
concentration of 10 ppm. When chitosan alone was used as a 
control, it showed no cytotoxicity. The authors also examined 
the macrophage cell morphology in a   monolayer culture after 
the treatment with varying concentrations of CS-AgNPs. 
Microscopic observations showed no distinct morphological 
changes in the cells treated with a   bactericidal dose (2 ppm) 
of CS-AgNPs, indicating healthy cells (Figure S2). However, 
in agreement with the   cytotoxicity results, treatment with 
nanoparticles at 10 ppm showed distinct morphological 
changes. The cells appeared to be clustered, and the cell-
spreading patterns were restricted compared with the patterns 
of control cells.
genotoxicity of CS-AgNPs
Various studies have shown that higher doses of nanoparticles 
mediate cell death by various mechanisms such as inducing 
apoptosis, DNA fragmentation, and DNA damage. In this 
study, the authors determined the DNA fragmentation and 
DNA damage in macrophages at the bactericidal and higher 
doses of CS-AgNPs. No laddering patterns were observed 
in the gel in control macrophages or those treated with 
CS-AgNPs at 3 ppm, whereas a higher dose of CS-AgNPs 
(10 ppm) showed a distinct ladder pattern after 6 hours of 
treatment (Figure 6A).
Chromosome abnormalities such as double-strand breaks 
are a direct consequence of DNA damage. DNA damage by 
CS-AgNPs was further studied using the comet assay. In 
this assay, the length of the tail increases with the extent of 
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DNA damage. Tail length of control DNA was compared 
with that of nanoparticle-treated cells, and the extent of dam-
age was assessed. Cells treated with CS-AgNPs showed a 
concentration-dependent increase in tail length as compared 
with control cells. No significant DNA damage was observed 
in control cells or cells treated with CS-AgNP at 3 ppm, 
whereas a comet-like tail, which implies DNA damage, was 
observed at the concentration of 20 ppm (Figure 6B). This 
observation was further supported by DAPI staining of the 
nucleus. As shown in Figure 6C, no significant changes in 
the nuclear morphology were observed at the concentration 
of 3 ppm. In contrast, nucleus shrinkage was observed in the 
macrophages treated with CS-AgNPs at 10 ppm.
Intracellular bacterial killing
Macrophages are professional phagocytic cells that can 
internalize particles up to 10 µm in size. The authors 
  hypothesized that exogenous addition of CS-AgNPs 
may lead to endocytosis of CS-AgNPs by macrophages, 
resulting in intracellular killing of bacteria. Fluorescent 
microscopy was used to determine if PI-labeled particles 
were   internalized by macrophages. Particle internalization 
was compared with free PI under identical conditions. 
The free PI showed minimal dye internalization but the 
macrophages showed active endocytosis of fluorescently 
labeled CS-AgNPs (Figure 7A).
The infection conditions and intracellular survival 
kinetics of M. smegmatis have been well characterized in 
macrophages.33 For this reason the authors chose these two 
models to evaluate the killing activity of M. smegmatis–
infected   macrophages after treatment with CS-AgNPs. 
  Macrophages were treated with CS-AgNPs (3 ppm) 1 hour 
before (pretreatment) and 1 hour after (post-treatment) 
M. smegmatis infection. As shown, this concentration of 
nanoparticles was found to be nontoxic to the macrophages 
(Figure 5). As shown in Figure 7B, increased dose-dependent 
reduction in intracellular bacterial survival was observed at 
6 hours in cells pretreated with CS-AgNPs, as compared 
with untreated and post-treated macrophages. Treatment 
with CS-AgNPs had no effect on the phagocytosis rate of 
bacteria (data not shown) when compared with untreated 
macrophages.
A
B
C
3 ppm Control 20 ppm
3 ppm Control 10 ppm
Figure 6 genotoxic activity of chitosan-stabilized silver nanoparticles (CS-AgNPs) on mouse macrophage RAW264.7 cells: (A) DNA fragmentation of macrophages treated 
with different concentrations of CS-AgNPs for 6 hours – DNA was isolated from untreated (lane 1), chitosan (lane 2), and CS-AgNP-treated (3 and 10 ppm, lanes 3 and 4, 
respectively) macrophages and electrophoresed on agarose gel; (B) comet analysis – control and CS-AgNP-treated (3 and 20 ppm) macrophages stained with propidium 
iodide (4 µg/mL); (C) DAPI (4, 6-diamidino-2-phenylindole) staining of control and CS-AgNP-treated (3 and 10 ppm) macrophages.
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Discussion
Pathogenic microorganisms adapt various strategies to 
counteract the effect of the anti-infective agent and estab-
lish the infection successfully. Therefore, it is important to 
design more effective therapeutic strategies, including new 
antibiotics to overcome these challenges. In recent times 
nanoparticles have received a great deal of attention as a 
therapeutic agent because of their wide range of bioactivi-
ties and unique mode of action. In this study, the authors 
have shown that a specific dose of CS-AgNPs can kill the 
bacteria without harming the host cells. It was shown that 
chitosan alone has antibacterial activity, which is depen-
dent on a number of factors such as the chitosan molecular 
weight; the   viscosity, ionic strength, pH, and presence 
of metallic ions in the medium; the temperature; and the 
concentration of chitosan in composite preparations.34,35 
The authors first determined a concentration of chitosan, 
which itself would not inhibit the bacterial growth and which 
was suitable for the preparation of bioactive nanoparticles. 
Chitosan binds to metal ions because of the presence of 
amine and hydroxyl groups.36 Under certain conditions 
chitosan can reduce silver ions to AgNPs,37 which become 
attached to the coating polymer and thus provide stability 
to the AgNPs. These CS-AgNPs are spherical and they are 
stable for a longer duration, as determined by UV-visible 
absorption spectra and TEM studies (Figure 1). As previ-
ously noted, the long-term stability of AgNPs in solution 
is an important goal to be reached.
In order to study the antibacterial activity of CS-AgNPs, 
killing kinetic assays were performed with different human 
pathogens. The present study showed distinct differences in 
the susceptibility of bacteria to CS-AgNPs. P . aeruginosa, 
S. typhi, and S. aureus were found to be more susceptible to 
the action of CS-AgNPs. In contrast, the inhibitory effect 
of nanoparticles was moderate in M. smegmatis. This 
  discrepancy may be due to differences in the membrane 
structure and the composition of the cell wall. The cell 
membrane of Gram-positive and Gram-negative bacteria 
has an overall negative charge because of the presence of 
teichoic acids and lipopolysaccharide (LPS), respectively. 
As chitosan is a cationic polymer, the potent bactericidal 
activity of CS-AgNPs against P . aeruginosa, S. typhi, and 
S. aureus could be because of strong interaction between 
cationic chitosan and the negatively charged molecules. In 
contrast, the mycobacteria cell wall is rich in lipids such as 
mycolic acids and this limits the binding and permeability 
of drug molecules. To study the mechanism by which CS-
AgNPs inactivate bacterial cells, the effect on cell integrity 
was evaluated by scanning electron microscopy. The results 
obtained indicated that irreversible damage could be induced 
on bacterial cells after direct contact with CS-AgNPs. The 
damage to the cell may be caused by interactions of AgNPs 
with phosphorous- and sulfur-containing compounds. Silver 
ions tend to have a high affinity for such molecules.38
Both P . aeruginosa and S. aureus are known to synthesize 
exopolysaccharides, protecting the bacteria from the host 
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Figure 7 Chitosan-stabilized silver nanoparticles (CS-AgNPs) exhibit intracellular killing activity against Mycobacterium smegmatis. (A) Cellular uptake of propidium (PI)-
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defense mechanisms. The antibiofilm activity could be due 
to inhibition of exopolysaccharide synthesis, because it has 
been shown that AgNPs impair exopolysaccharide   synthesis 
in P . aeruginosa, limiting the formation of biofilm.12 In 
comparison, the inhibition of biofilm formation was more 
potent in P . aeruginosa. This distinction could be because 
of the presence of abundant LPS, which leads to strong 
interaction with CS-AgNPs, produced by P . aeruginosa. It is 
known that P . aeruginosa cells synthesize more LPS than S. 
aureus. The inhibitory effect could also be due to diffusion 
of CS-AgNPs through the channels present in the biofilms, 
which may then impart antimicrobial functions. Altogether, 
these results indicate that chitosan-based AgNPs not only 
exhibit potent bactericidal activity but also impede the for-
mation of biofilm.
An important aspect for any molecule to be used as a 
therapeutic agent is that the molecule should eliminate the 
target without affecting the viability of mammalian cells. 
Many medically relevant nanoparticles such as gold and silver 
have been investigated for their cytotoxic effect, but different 
researchers have reported varying effects for these nanoparti-
cles on mammalian cells. These differences have been largely 
attributed to individual AgNP preparation methodologies 
and target cells. Gold nanoparticles showed no significant 
toxicity in HeLa cells,39,40 while significant size-dependent 
toxicity was observed in fibroblasts, epithelial cells, and 
melanoma cells.41 AgNPs that did not contain any surface 
modifiers or stabilizers have been shown to have a signifi-
cant cytotoxic effect on mouse macrophage J774.A1 cells,42 
whereas starch-capped AgNPs have been shown to have no 
effect on cancer cells U251 and   fibroblasts IMR-90 because 
of the slow release of silver ions from the gel matrix.43 In 
this study the cytotoxic effect on mouse   macrophage cell line 
RAW264.7 was analyzed and CS-AgNPs were found to have 
no cytotoxic effect at the bactericidal dose after 24 hours. 
When chitosan alone was used as a control, it showed no 
significant cytotoxicity in macrophages. This observation 
indicates biocompatibility of chitosan as a capping agent 
in nanoparticles. Microscopic observations of macrophages 
treated with the bactericidal dose of nanoparticles did not 
show distinct changes when compared with control cells, 
whereas treatment with a high dose (10 ppm) showed abnor-
mal morphology and few cellular extensions. This could be 
because of disturbances in cytoskeletal function as a result 
of nanoparticle treatment. Similar results were obtained with 
U251 and dermal fibroblast cells treated with starch-capped 
AgNPs and citrate-coated gold particles.43,44 Furthermore, the 
comet and DNA fragmentation assays showed no significant 
DNA damage at the bactericidal dose, whereas treatment 
with a higher dose of CS-AgNPs showed increase in tail 
length, which   signifies DNA damage, and a DNA ladder 
pattern. The presence of AgNPs induces formation of reac-
tive oxygen species, which is considered to be the major 
source of DNA damage. Reactive oxygen species-mediated 
genotoxicity has been previously observed for metal oxide 
nanoparticles and starch-capped AgNPs.43,45 Further damage 
may occur from interaction of silver ions with DNA, which 
causes changes in the conformation of DNA. Altogether, 
these results indicate that CS-AgNPs have no cytotoxic or 
genotoxic effect on macrophages at the bactericidal dose, 
but they cause toxic effects when applied above a certain 
concentration level.
Macrophages can internalize any particle ranging 
up to 10 µm in size.46 Previous studies have shown that 
latex beads and antimicrobial peptides target the mac-
rophage   phagosomes, resulting in increased maturation 
of   phagosomes46 and intracellular killing of S. aureus,47 
  respectively. The authors also observed active uptake of 
PI-labeled CS-AgNPs by macrophages. The increase in 
intracellular killing of M. smegmatis could be because of 
the delivery of endocytosed AgNPs to macrophage phago-
somes where M. smegmatis resides; alternatively, it could 
be because of the activation of macrophages, as treatment 
with AgNPs upregulate the expression of proinflammatory 
genes such as interleukin-1, interleukin-6, and tumor necrosis 
factor-alpha.42 These cytokines activate the cells, resulting in 
an increase in the killing efficiency of macrophages.
Conclusion
The antibacterial activities of CS-AgNPs against M. smegmatis,   
P . aeruginosa, S. typhi, and S. aureus were compared. 
CFU assay results showed that CS-AgNPs exhibit potent 
  antibacterial activities against Gram-positive and Gram-
negative bacteria, followed by acid-fast M. smegmatis. The 
antibacterial activities are time and concentration   dependent. 
Most of the bacterial killing happened in the first hour of 
incubation, and the bacteria kill rate increased continu-
ously with the increase in incubation time and nanomaterial 
  concentration. The bacterial death may be attributed to cell 
membrane disruption or inactivation of thiol-containing 
proteins. The biofilm assay results showed that CS-AgNPs 
exhibit potent antibiofilm activity against P . aeruginosa, 
whereas treatment of S. aureus with the same concentra-
tion showed no significant inhibition in biofilm formation. 
The MTT and cell morphology analysis results showed 
that CS-AgNPs exhibit no discernible cytotoxic effect on 
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macrophages at the bactericidal concentration. In contrast, 
treatment with higher doses caused significant decrease in cell 
viability. The genotoxic approach was employed to elucidate 
the involvement of CS-AgNPs in DNA damage and DNA 
fragmentation. The results indicated no significant DNA dam-
age or fragmentation at the bactericidal dose, whereas treat-
ment with a higher concentration set off DNA damage and 
nucleus shrinkage, as determined by comet assay and DAPI 
staining. The results from this research also indicated that PI-
labeled CS-AgNPs are actively endocytosed by macrophages, 
which leads to intracellular killing of M. smegmatis. The 
present study concludes that chitosan-based AgNPs exhibit 
potent antibacterial and antibiofilm activity, they do not 
exhibit cytotoxic or genotoxic effects on macrophages at the 
bactericidal concentration, and they kill mycobacteria resid-
ing inside the macrophages. Therefore, CS-AgNPs represent 
a potential template for the design of antibacterial agents to 
decrease bacterial colonization and to overcome the problem 
of drug resistance.
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Control 3 ppm 10 ppm
Figure S2 Cytotoxicity of chitosan-stabilized silver nanoparticles (CS-AgNPs) on mouse macrophage RAW264.7 cells. Cell morphology of RAW264.7 macrophages after 
treatment with different concentrations (3 and 10 ppm) of CS-AgNPs for 24 hours. Cells grown in medium and chitosan were used as a control.
Chitosan CS-AgNPs
Figure S1 Antibacterial activity of silver nanoparticles (AgNPs) by agar diffusion method: chitosan-stabilized AgNPs (CS-AgNPs) at 2 ppm were loaded into the wells formed 
on plates containing a lawn of Staphylococcus aureus; growth inhibition was determined by measuring the zone of inhibition after 24 hours; chitosan was used as a control.
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